Novartis Cash Flow Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | 9,115.0 | 9,014.0 | 8,080.0 |
| Net Investing Cash Flow | 1,382.0 | (6,575.0) | (7,482.0) |
| Net Financing Cash Flow | (9,254.0) | (4,970.0) | (266.0) |
| Net Change in Cash | 1,545.0 | (2,506.0) | 238.0 |
| Depreciation & Amortization | -- | 2,026.0 | 1,765.0 |
| Capital Expenditures | (2,549.0) | (1,802.0) | (1,188.0) |
| Cash Dividends Paid | (2,638.0) | (2,084.0) | (2,139.0) |






